RGEBX | TBDAX | RGEBX / TBDAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 25 years | - |
Gain YTD | 21.295 | 24.261 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 290B | 350M | 82,857% |
Annual Yield % from dividends | 0.16 | 0.00 | - |
Returns for 1 year | 29.29 | 42.41 | 69% |
Returns for 3 years | -1.04 | 2.64 | -39% |
Returns for 5 years | 50.58 | 52.65 | 96% |
Returns for 10 years | 62.11 | 68.37 | 91% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TILWX | 28.40 | -0.06 | -0.21% |
Nuveen Large Cap Growth W | |||
EILVX | 26.44 | -0.06 | -0.23% |
Eaton Vance Large-Cap Value I | |||
BNUEX | 10.61 | -0.04 | -0.38% |
UBS International Sustainable Equity P | |||
SHPCX | 14.43 | -0.10 | -0.69% |
Saratoga Health & Biotechnology C | |||
FAFCX | 31.08 | -0.25 | -0.80% |
Fidelity Advisor Financials C |